Basic Study
Copyright ©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 724-734
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.724
Figure 1
Figure 1 Teneligliptin ameliorated myocardial hypertrophy in streptozotocin-induced diabetic mice. A: Molecular structure of teneligliptin; B: Quantitative analysis of cardiomyocyte area; C: Heart weight/tibia length. aP < 0.05 vs control group; bP < 0.05 vs streptozotocin group, n = 8. STZ: Streptozotocin.